Absence of intracellular lipolytic inhibitor G0S2 enhances intravascular triglyceride clearance and abolishes diet-induced hypertriglyceridemia

Yongbin Chen; Scott M. Johnson; Stephanie D. Burr; Davide Povero; Aaron M. Anderson; Cailin E. McMahon; Jun Liu

doi:10.1172/JCI181754

Absence of intracellular lipolytic inhibitor G0S2 enhances intravascular triglyceride clearance and abolishes diet-induced hypertriglyceridemia

Yongbin Chen,¹ Scott M. Johnson,² Stephanie D. Burr,¹ Davide Povero,¹ Aaron M. Anderson,³ Cailin E. McMahon,¹ and Jun Liu¹

Published March 18, 2025 - More info

View PDF

Abstract

The interplay between intracellular and intravascular lipolysis is crucial for maintaining circulating lipid levels and systemic energy homeostasis. Adipose triglyceride lipase (ATGL) and lipoprotein lipase (LPL), the primary triglyceride (TG) lipases responsible for these two spatially separate processes, are highly expressed in adipose tissue. Yet, their coordinated regulation remains undetermined. Here, we demonstrate that genetic ablation of G0S2, a specific inhibitory protein of ATGL, completely abolishes diet-induced hypertriglyceridemia and significantly attenuates atherogenesis in mice. These effects are attributed to enhanced whole-body TG clearance, not altered hepatic TG secretion. Specifically, G0S2 deletion increases circulating LPL concentration and activity, predominantly through LPL production from white adipose tissue (WAT). Strikingly, transplantation of G0S2-deficient WAT normalizes plasma TG levels in mice with hypertriglyceridemia. In conjunction with improved insulin sensitivity and decreased ANGPTL4 expression, the absence of G0S2 enhances the stability of LPL protein in adipocytes, a phenomenon that can be reversed upon ATGL inhibition. Collectively, these findings highlight the pivotal role of adipocyte G0S2 in regulating both intracellular and intravascular lipolysis, and the possibility of targeting G0S2 as a viable pharmacological approach to reduce circulating TGs.

Absence of intracellular lipolytic inhibitor G0S2 enhances intravascular triglyceride clearance and abolishes diet-induced hypertriglyceridemia

Yongbin Chen,¹ Scott M. Johnson,² Stephanie D. Burr,¹ Davide Povero,¹ Aaron M. Anderson,³ Cailin E. McMahon,¹ and Jun Liu¹

Article tools

Metrics

Go to

Absence of intracellular lipolytic inhibitor G0S2 enhances intravascular triglyceride clearance and abolishes diet-induced hypertriglyceridemia

Yongbin Chen,1 Scott M. Johnson,2 Stephanie D. Burr,1 Davide Povero,1 Aaron M. Anderson,3 Cailin E. McMahon,1 and Jun Liu1

Article tools

Metrics

Go to

Sign up for email alerts

Yongbin Chen,¹ Scott M. Johnson,² Stephanie D. Burr,¹ Davide Povero,¹ Aaron M. Anderson,³ Cailin E. McMahon,¹ and Jun Liu¹